Bircan Kayaaslan

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

Mine Durusu Tanrıöver, Levent Doğanay, Murat Akova et al. · The Lancet · 2021 · 922 citations · Full text

Higher viral loads in asymptomatic COVID-19 patients might be the invisible part of the iceberg

İmran Hasanoğlu, Gülay Korukluoğlu, Dilek Asiltürk et al. · Infection · 2020 · 112 citations · Full text

Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study

Niccolò Buetti, Alexis Tabah, Ambre Loiodice et al. · Critical Care · 2022 · 57 citations · Full text

COVID-19 experience of the major pandemic response center in the capital: results of the pandemic’s first month in Turkey

Rahmet Güner, İmran Hasanoğlu, Bircan Kayaaslan et al. · TURKISH JOURNAL OF MEDICAL SCIENCES · 2020 · 40 citations · Full text

A long-term multicenter study: Entecavir versus Tenofovir in treatment of nucleos(t)ide analogue-naive chronic hepatitis B patients

Bircan Kayaaslan, Zeliha Koçak Tufan, Saygın NAYMAN ALPAT et al. · Clinics and Research in Hepatology and Gastroenterology · 2017 · 17 citations

Hepatology, Viral Hepatitis, Immunology +10